Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sebacic acid is a naturally occurring dicarboxylic fatty acid with the chemical formula C10H18O4. It is classified as an alpha,omega-dicarboxylic acid and is found in human and plant metabolism[1][2][3]. Sebacic acid has been studied for its potential metabolic effects; oral administration in humans has been shown to reduce postprandial hyperglycemia in type 2 diabetic subjects by lowering hepatic glucose output and increasing peripheral glucose disposal. In vitro studies indicate that it increases insulin-mediated glucose uptake and GLUT4 expression in muscle cells[7]. Its mechanism of action may involve inhibition of hemoglobin subunit alpha[2], though this requires further validation. Sebacic acid also plays a role as a precursor or metabolite involved in inflammatory skin conditions via conversion to pro-inflammatory analogs acting on the OXER1 receptor[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sebacic acid.